No Detail Found!

Expression and diagnostic value of gfap, nse combined with s100β in patients with sepsis-related encephalopathy

Author(s)
Jixiang Zhu Department of Critical Care Medicine, Hunan Cancer Hospital,,China
Jianghong Zhao Department of Critical Care Medicine, Hunan Cancer Hospital,,China
Shufang Wang Department of Critical Care Medicine, Changsha Central Hospital, University of South China,,
Xiaowei Dai Department of Critical Care Medicine, Changsha Central Hospital, University of South China,,
Xiaoxia Wu Department of Critical Care Medicine, Changsha Central Hospital, University of South China,,
Jing Nie Department of Critical Care Medicine, Hunan Cancer Hospital,,China
Abstract
To study the expressions of glial fibrillary acidic protein (GFAP), Neuron-specific en ase (NSE) combined with S100ß in patients with sepsis-associated encephalopathy (SAE) and their diagnostic value. Methods: A total of 186 sepsis patients admitted to the ICU of our hospital from January 2019 to January 2022 were selected and divided into the SAE group of 86 cases and the non-SAE group of 100 cases according towhether the patients had SAE or not. The clinical data (general data, laboratory indicators) of the two groups were collected, serum GFAP, NSE, And S100ß levels were determined, and the degree of brain injury was evaluated according to the Glasgow Coma Scale (GCS), and the 28-day prognosis and survival of the patients were analyzed. The ROC curve was used to analyze the predictive value of GFAP, NSE and S100ß on the occurrence of the same. Logistic regression was used to analyze the factors affecting the occurrence of SAE. Results: The levels of GFAP, NSE and S100ß were higher than those in the non-SAE group (P<0.05). Logistic regression analysis showed that combined hyperuricemia, high Hcy, high SOFA score, high APACHE II score, high PCT level, high CRP level, high GFAP level, high NSE level, High S100ß level was associated with the occurrence of SAE (P <0.05). The 28day mortality in the SAE group was higher than that in the non-SAE group [31.40% (27/86) vs 10.00% (10/100)] (?2=13.282, P < 0.05). With the aggravation of brain injury in SAE patients, the levels of GFAP, NSE, And S100ß gradually increased. Pearson correlation analysis showed that the levels of GFAP, NSE and S100ß were correlated with the degree of brain injury in SAE patients (P<0.05). The levels of GFAP, levels of GFAP, NSE and S100ß in SAE death patients were higher than those in surviving patients (P<0.05) showing that the levels of GFAP, NSE and S100ß were associated with the 28-day prognosis of SAE patients (P<0.05). The ROC curve showed that GFAP, NSE combined with S100ßhad better diagnostic value for SAE (AUC=0.934, 95%CI=0.7960.962, P < 0.05) Pearson correlation analysis showed that GFAP was positively correlated with NSE (r=0.453, P<0.05). GFAP was positively correlated with S100ß (r=0.443, P < 0.05); NSE was positively correlated with S100ß (r=0.620, P < 0.05). The occurrence of SAE is affected by a variety of factors. GFAP, NSE, and S100ß are elevated in this disease and are related to the degree of brain injury and prognosis of patients. When the level is =0.56 mg/L, it indicates a higher risk of SAE and can be used for early diagnosis of this disease.
Publication Details
Page(s) 2156-2164
DOI DOI not available
Published Journal: Bioscience Research, Volume: 19, Issue: 4, Year: 2022

Request the full text from PASTIC

Keywords
Neuron-specific enolase, Sepsis-associated encephalopathy, According to beta protein, Glial fibrillary autoprotein
0

Citations

0

Downloads

140

Views